Andrew Sinclair, Ph.D.
Lead Independent DirectoratAdicet Bio· In proxies 2023–2025
Andrew Sinclair, Ph.D. sits on 15 public boards.
Experience
- Adicet BioPublic company · 3 yr
- Lead Independent Director2023 – Present · 3 yrStock in role -97%
- Scholar Rock Holding CorporationPublic company · 2 yr
- Director2024 – Present · 2 yrNo stock prices for these years
- BiVictriX TherapeuticsPublic company · 4 yr
- Director2022 – Present · 4 yrNo stock prices for these years
- Mirror Biologics, Inc.Public company · 4 yr
- Director2022 – Present · 4 yrNo stock prices for these years
- Parthenon Therapeutics, Inc.Public company · 4 yr
- Director2022 – Present · 4 yrNo stock prices for these years
- Karyopharm Therapeutics Inc.Public company · 6 yr
- Director2020 – Present · 6 yrNo stock prices for these years
- Soleno Therapeutics, Inc.Public company · 8 yr
- Director2018 – Present · 8 yrNo stock prices for these years
- Kezar Life Sciences, Inc.Public company · 9 yr
- Director2017 – Present · 9 yrNo stock prices for these years
- Verastem Inc.Public company · 14 yr
- Director2012 – Present · 14 yrNo stock prices for these years
- Alliance for Cancer Gene TherapyPublic company
- Director? – PresentNo stock prices for these years
- California Life SciencesPublic company
- Director? – PresentNo stock prices for these years
- Carbon Biosciences, Inc.Public company
- Director? – PresentNo stock prices for these years
- Incendia Therapeutics, Inc.Public company
- Director? – PresentNo stock prices for these years
- Proteolix Inc.Public company · 17 yr
- Director2009 – Present · 17 yrNo stock prices for these years
- Infinity Pharmaceuticals, Inc.Public company
- Director? – PresentNo stock prices for these years
- Sierra Oncology, Inc.Public company · 3 yr
- Director2019 – 2022 · 3 yrNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?